13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q4 2023. See the latest, Q2 2026 →
Reported value
$27.30B
+11% on the quarter before
Positions
79
18 new · 19 sold out
Top 10
40.2%
of the value
Est. gain
+$2.54B
on stocks held all quarter
Est. return
+14.9%
on those stocks since Q3 2023
Positions as of Dec 31, 2023, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2023. Striped tiles are options.
Largest buys
Since Q3 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Progressive Corp~$751.5MAdded · 0.6% → 3.4%+4,718,237 shares
- AMD~$698.3MNew · 0.0% → 2.6%+4,737,399 shares
- Deere & Co~$562.4MNew · 0.0% → 2.1%+1,406,562 shares
- Alphabet~$460.1MNew · 0.0% → 1.7%+3,293,461 shares
- Cboe Global Mkts Inc~$430.8MNew · 0.0% → 1.6%+2,412,499 shares
- Us Bancorp Del~$414.2MNew · 0.0% → 1.5%+9,569,638 shares
- Take-Two Interactive Softwar~$388.2MNew · 0.0% → 1.4%+2,412,234 shares
- Lamb Weston Hldgs Inc~$383.2MNew · 0.0% → 1.4%+3,545,376 shares
- Mastercard~$368.9MAdded · 0.5% → 1.8%+864,943 shares
- Mckesson Corp~$359.0MAdded · 2.6% → 3.8%+775,480 shares
Largest sells
Since Q3 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$955.0MSold out · 3.9% → 0.0%−3,024,399 shares
- Unitedhealth Group Inc~$735.6MCut · 3.8% → 0.9%−1,397,162 shares
- Amazon~$580.5MCut · 4.5% → 2.7%−3,820,344 shares
- Block~$545.5MSold out · 2.2% → 0.0%−12,324,808 shares
- Ppg Inds Inc~$459.9MCut · 2.1% → 0.5%−3,075,378 shares
- Fortinet~$413.7MSold out · 1.7% → 0.0%−7,050,550 shares
- Cadence~$388.1MCut · 1.6% → 0.2%−1,424,748 shares
- General Electric Co~$371.5MCut · 3.6% → 2.4%−2,910,508 shares
- Visa Inc.~$333.6MCut · 6.5% → 5.4%−1,281,229 shares
- Workday~$311.9MCut · 4.6% → 4.2%−1,129,921 shares
Holdings
As of Dec 31, 2023. Changes are in shares against Sep 30, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Visa Inc.COM CL A · shares −18% · price +13.2% | 5.4% | $1.48B | +$172.6M | ||||||||
| United Parcel Service IncCL B · shares +23% · price +0.9% | 4.7% | $1.29B | +$9.1M | ||||||||
| Api Group CorpCOM STK · shares +0.3% · price +33.4% | 4.3% | $1.19B | +$296.5M | ||||||||
| WorkdayCL A · shares −22% · price +28.5% | 4.2% | $1.13B | +$251.4M | ||||||||
| MetaCL A · shares −2.1% · price +17.9% | 3.9% | $1.06B | +$160.8M | ||||||||
| Mckesson CorpCOM · shares +53% · price +6.5% | 3.8% | $1.03B | +$41.0M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price +53.1% | 3.7% | $1.01B | +$351.7M | ||||||||
| Progressive CorpCOM · shares +412% · price +14.3% | 3.4% | $933.9M | +$22.9M | ||||||||
| Danaher CorporationCOM · shares −2.6% · price −6.8% | 3.4% | $926.4M | −$67.1M | ||||||||
| Philip Morris Intl IncCOM · shares +61% · price +1.6% | 3.3% | $905.4M | +$9.0M | ||||||||
| Roivant Sciences LtdSHS · shares −5.5% · price −3.9% | 2.9% | $779.0M | −$31.2M | ||||||||
| Fortive CorpCOM · shares +26% · price −0.7% | 2.8% | $775.0M | −$4.4M | ||||||||
| AmazonCOM · shares −44% · price +19.5% | 2.7% | $749.0M | +$122.4M | ||||||||
| Ameriprise Finl IncCOM · shares +10% · price +15.2% | 2.7% | $727.1M | +$87.0M | ||||||||
| AMDCOM · shares New | 2.6% | $698.3M | — | ||||||||
| Hdfc Bank LtdSPONSORED ADS · shares −3.7% · price +13.7% | 2.4% | $653.7M | +$78.9M | ||||||||
| General Electric CoCOM NEW · shares −36% · price +15.5% | 2.4% | $649.2M | +$86.9M | ||||||||
| Deere & CoCOM · shares New | 2.1% | $562.4M | — | ||||||||
| MastercardCL A · shares +296% · price +7.7% | 1.8% | $493.6M | +$8.9M | ||||||||
| Biomarin Pharmaceutical IncCOM · shares +16% · price +9.0% | 1.7% | $471.4M | +$33.5M | ||||||||
| Freeport-McMoRanCL B · shares +13% · price +14.2% | 1.7% | $470.5M | +$51.6M | ||||||||
| AlphabetCAP STK CL A · shares New | 1.7% | $460.1M | — | ||||||||
| Cboe Global Mkts IncCOM · shares New | 1.6% | $430.8M | — | ||||||||
| Us Bancorp DelCOM NEW · shares New | 1.5% | $414.2M | — | ||||||||
| Rayzebio IncCOM · shares 0% · price +180.0% | 1.5% | $413.0M | +$265.5M | ||||||||
| Total · 79 positions | 100% | $27.30B | +$2.54B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2023 to Q4 2023: 60 stocks held throughout, up $2.54B (+14.9%).
- Bridgebio Pharma Inc+$351.7M+53%
- Api Group Corp+$296.5M+33%
- Rayzebio Inc+$265.5M+180%
- Workday+$251.4M+28%
- Visa Inc.+$172.6M+13%
- Everest Group Ltd−$11.8M−5%
- Adaptive Biotechnologies Cor−$16.5M−10%
- Ginkgo Bioworks Holdings Inc−$17.2M−7%
- Roivant Sciences Ltd−$31.2M−4%
- Danaher Corporation−$67.1M−7%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |